Overview
Protionamide is a second-line antituberculosis agent belonging to the thioamide class. It is structurally related to ethionamide and is used primarily in cases of multidrug-resistant tuberculosis (MDR-TB) where first-line drugs like isoniazid and rifampin are ineffective. The drug is typically administered orally and is often used in combination with other antitubercular medications to prevent resistance development. Its mechanism of action involves inhibition of mycolic acid synthesis, which is essential for the mycobacterial cell wall.
Physical and Chemical Properties
Protionamide appears as a white to pale yellow crystalline powder with a melting point of 142-145 °C. It is slightly soluble in water but dissolves more readily in organic solvents such as ethanol and acetone. The compound is stable under recommended storage conditions but may degrade when exposed to light, moisture, or extreme temperatures. Its molecular formula is C9H12N2S, with a molecular weight of 180.27 g/mol.
Main Applications
Protionamide is primarily used in the treatment of multidrug-resistant tuberculosis (MDR-TB), particularly in cases where first-line drugs have failed. It is often part of combination therapy regimens to enhance efficacy and reduce the risk of resistance. The drug is also occasionally used in the treatment of leprosy, though its application in this area is less common. Due to its potential side effects, its use is strictly regulated and requires medical supervision.
Safety and Storage
Protionamide should be stored in a cool, dry place, protected from light and moisture to maintain stability. Improper storage can lead to degradation and reduced efficacy. Safety precautions include monitoring for hepatotoxicity, gastrointestinal disturbances, and peripheral neuropathy. Patients with liver disease or a history of alcohol abuse should use the drug with caution. Healthcare providers must ensure proper dosing and adherence to treatment protocols.
B2B Procurement Guide
When procuring protionamide for pharmaceutical use, buyers should prioritize suppliers that comply with international standards such as USP (United States Pharmacopeia) or EP (European Pharmacopoeia). Batch-specific certificates of analysis (CoA) should be reviewed for purity, potency, and impurity profiles. Due to its specialized application, procurement often involves direct engagement with manufacturers or authorized distributors. Buyers should also verify regulatory approvals (e.g., FDA, EMA) for the intended market. Pricing varies based on quantity and supplier, but bulk purchases may offer cost advantages.